| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.95B | $2.01B | $1.73B |
| YoY Revenue Growth % | -2.9% | +16.4% | — |
| Gross Profit | $549.3M | $585.9M | — |
| Gross Margin % | 28.2% | 29.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $78.5M | $97.4M | $76.9M |
| Operating Margin % | 4.0% | 4.8% | 4.5% |
| Net Income (GAAP) | -$339.8M | -$193.4M | -$430.7M |
| EBITDA (Normalized) | $102.5M | $123.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$140.0M | $135.1M | $74.2M |
| Capital Expenditures (CapEx) | $30.0M | $32.3M | — |
| Free Cash Flow (FCF) | -$170.0M | $102.8M | $74.2M |
| FCF Margin % | -8.7% | 5.1% | 4.3% |
| Return on Invested Capital (ROIC %) | 95.0% | 95.0% | — |
| Cash & Short-Term Equivalents | $413.9M | $376.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$282.6M | -$283.4M | — |